GlaxoSmithKline Pharmaceuticals is trading 1.76% higher at ₹2,486, within a range of ₹2,405–₹2,492. The stock is down 1.17% YTD but up 1.79% in the last 5 days. Its TTM P/E of 47.17 is well above the sector average of 23.40. The company reported a net profit of ₹257.49 crore in the last quarter. As of Dec 2025, MF holding declined to 4.77% and FII holding fell to 4.63%.

#FundamentalViews

562 likes·68 comments